What stock do these 3 billionaires have in common?
What do billionaires Paul Tudor-Jones, NY Mets owner Steve Cohen, and "The World's Greatest Investor" Jim Simons all have in common? (See their latest move here.)
These three billionaires bought one controversial stock. A stock profiting from a major economic trend, six DECADES in the making.
But why does this matter to you?
Because, as the media force-feeds you stories about AI stocks (like Nvidia) ... the real financial story is playing out, right under your nose.
A former Goldman Sachs banker named Dr. David "Doc" Eifrig explains what is underway, in a brand-new analysis, right here.
Doc reveals how many of America's most influential people have a vested interest in this stock's continued success... and goes as far as to call this company "America's #1 Retirement Stock."
On one side, says Dr. Eifrig, stand the billionaires I just mentioned... along with BlackRock, the world's richest asset manager... and other investing royalty.
Chances are, they'll continue to get richer.
But on the other side, says Dr. Eifrig, stand most Americans... regular folks who don't understand what's going on. They are sitting paralyzed by this choppy market... and missing a giant opportunity.
Take a few minutes to get the facts for yourself.
Doc and his team have produced a brand-new analysis, which explains everything you need to know, including exactly what these billionaires – and others – are doing, and the 3 steps he strongly recommends you take right now.
We've posted this brand-new work on our website. You can check it out free of charge.
Sincerely,
Kelly Brown
Senior Analyst, Stansberry Research
P.S. This stock already boasts twice the returns of Tesla... and Doc predicts it could quadruple in the coming years.
This message is a paid advertisement sent on behalf of Stansberry Research, a third-party advertiser of The Early Bird and MarketBeat.
This ad is sent on behalf of Stansberry Research, 1125 N Charles St, Baltimore, MD 21201. If you would like to optout from receiving offers from Stansberry Research please click here.
If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.
If you no longer wish to receive email from The Early Bird, you can unsubscribe.
© 2006-2023 American Consumer News, LLC dba MarketBeat.
326 E 8th St #105, Sioux Falls, SD 57103. United States.
No comments:
Post a Comment